
Federal Rule Extends Telehealth Prescribing for Buprenorphine Up to Six Months—No In-Person Visit Required
DEA and HHS codify pandemic-era flexibility, allowing providers to initiate and maintain buprenorphine treatment entirely via telehealth through the end of 2026, a move experts say could save lives and reshape addiction care nationwide.







